Accent Microcell Limited

Accent Microcell Limited

NNSE:ACCENTMIC
605.00
INR
+4.35
(+0.72%)
18.65EPS
19.05P/E
8.52BMarket Cap
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
Revenue per Share
59.59
74.49
88.68
143.73
119.32
148.42
Basic EPS, GAAP
2.16
2.65
5.5
17.66
14.91
18.65
Free Cash Flow per Basic Share
-0.05
4.95
1.57
-1.16
-5.48
-29.35
Dividend per Share
- -
0.19
0.46
0.61
0.95
1.02
Book Value per Share
11.97
14.43
22.67
73.65
87.56
114.84
Tangible Book Value per Share
11.9
14.4
22.21
73.64
87.56
114.83
Basic Weighted Avg Shares
22
22
22
17
22
24
Sales/Revenue/Turnover
1,326
1,657
1,973
2,455
2,646
3,490
Operating Margin (%)
6.67
5.53
7.56
14.89
14.57
15.13
Depreciation Expense
36
41
41
44
42
47
Net Income, GAAP
48
59
122
302
331
439
Effective Tax Rate (%)
19.99
22.35
17.34
17.41
24.44
24.72
Profit Margin (%)
3.62
3.56
6.2
12.29
12.5
12.57
Working Capital
150
100
239
1,256
1,240
1,114
LT Debt
178
69
55
15
9
3
Total Equity
266
321
504
1,638
1,948
2,755
Return on Invested Capital (%)
- -
12.53
19.09
22.58
15.49
16.71
Return on Capital (%)
- -
14.19
21.63
24.81
17.85
18.71
Return on Common Equity (%)
- -
20.07
29.65
28.16
18.44
18.65

Capital Structure

INR

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

INR

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
72.57%
41.42%
Free Cash Flow
- -
-1,818.46%
467.77%
Net Income, GAAP
- -
63.83%
32.65%
Sales/Revenue/Turnover
- -
21.64%
31.92%
Total Cash Common Dividend
- -
- -
14%

Semi-annual Revenue

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
2,455
2025
- -
- -
2,646
2026
- -
- -
3,490

Semi-annual Earnings Per Share

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
17.66
2025
- -
- -
14.91
2026
- -
- -
18.65

Semi-annual Dividends Per Share

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.61
2025
- -
- -
0.95
2026
- -
- -
1.02

Company Description

CEO
Ghanshyam Arjanbhai Patel
Full Time Employees
260
Sector
Health technology
Industry
Pharmaceuticals: major
Address
314, Shangrilla Arcade, Shyamal Cross Road, Anandnagar Road, Satellite Ahmedabad GU India 380015
IPO Date
Dec 15, 2023
Business
Accent Microcell Ltd. (NSE:ACCENTMIC) manufactures, sells, and trades cellulose-based excipients primarily for the pharmaceutical industry in India and internationally. The company offers microcrystalline cellulose (including spray-dried and spin flash-dried grades), powdered cellulose, microcrystalline cellulose spheres, silicified microcrystalline cellulose, crosscarmellose sodium, magnesium stearate, and microcrystalline cellulose with carboxymethyl cellulose; it sells these products under the Accel, Vincel, Acrocell, and Maccel brands. Accent Microcell also serves diverse sectors including nutraceuticals, food, bakery, dairy, meat and seafood, extrusion, cosmeceuticals and personal care, welding, paints, cement, construction, ceramics, rubber, enzymes, textile, leather, paper, boards, welding electrodes, filtration, and plastics, with exports to approximately 36 countries. In addition, the company provides supply chain management, on-time material delivery, customer assistance, and quality commitment services. Founded in 2001 and headquartered in Ahmedabad, Gujarat, India, Accent Microcell operates manufacturing facilities at Pirana (Unit-I) and Dahej SEZ (Unit-II). Recent developments include its public listing on the National Stock Exchange (NSE) in 2023, robust financial performance with revenue of INR 278 crore and profit of INR 34.7 crore for the trailing twelve months as of late 2025, and board approval of unaudited half-year results for the period ended September 30, 2025, alongside statements on IPO proceeds utilization in October 2025. The company has maintained strong profit growth at a 51.2% CAGR over the last five years, reduced debt levels to near debt-free status, and recommended a final dividend of INR 1.00 per equity share for fiscal year 2025.